CP, regarding: PPHM @NY Academy of Sciences Symposium...
one line jumps off the page to me and that is the Presentation Title:
"Immune Checkpoint Inhibitors; Assessing the Activity of Bavituximab"
Could this presentation show how PPHM plans on testing Phase III subjects to determine they are benefiting? If so, to me that will be the day they explain why they won't need 2 to 3 years to show the benefit of bavi in Phase III
Perhaps they will only need a couple months? That is why they will need Hockey Stick Patient Enrollment
Thoughts?
GLTA SHareholders, cancer Patients, and their families!!!